GlassScriptPhysician profile
Sumukh Arun Kumar
NPI 1003487323
$1,569.23
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $12.57 · 2022: $384 · 2023: $504 · 2024: $669.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,073 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,072.52 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $346.48 | 2022-2023 | Opdivo |
| Bayer Healthcare Pharmaceuticals INC. | $177.02 | 2022-2024 | |
| Gilead Sciences, INC. | $162.98 | 2023-2024 | Veklury |
| Astrazeneca Pharmaceuticals LP | $125.86 | 2022-2024 | Farxiga, Airsupra |
| Abbvie INC. | $107.03 | 2023-2024 | Botox |
| Seagen INC. | $99.99 | 2024 | |
| Novo Nordisk INC | $85.78 | 2024 | Ozempic, Rybelsus |
| Takeda Pharmaceuticals U.S.A., INC. | $73.92 | 2023-2024 | Entyvio |
| Alexion Pharmaceuticals, INC. | $70.27 | 2022-2024 | |
| Pfizer INC. | $69.00 | 2022-2024 | |
| Glaxosmithkline, LLC. | $63.74 | 2022-2023 | Trelegy Ellipta |
| Argenx US, INC. | $61.10 | 2024 | Vyvgart Hytrulo |
| Grifols USA, LLC | $34.58 | 2024 | Gamunex-C |
| Karyopharm Therapeutics INC. | $31.91 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.74 | 2021-2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $28.83 | 2024 | Jynarque |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sumukh Arun Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.